A clinical and molecular Phase II trial of oral ENMD-2076 in ovarian clear cell carcinoma (OCCC): A study of the Princess Margaret Phase II Consortium
Lheureux, Stephanie, Tinker, Anna V, Clarke, Blaise A., Ghatage, Prafull, Welch, Stephen, Weberpals, Johanne I, Dhani, Neesha C, Butler, Marcus O, Tonkin, Katia, Tan, Qian, Tan, David S.P., Brooks, KeLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-1244
Date:
August, 2018
File:
PDF, 2.31 MB
english, 2018